Literature DB >> 31793396

Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients

Marco Puzzoni1, Pina Ziranu1, Laura Demurtas1, Eleonora Lai1, Stefano Mariani1, Nicole Liscia1, Paolo Soro1, Andrea Pretta1, Valentino Impera1, Silvia Camera1, Francesca Musio1, Mara Persano1, Clelia Donisi1, Simona Tolu1, Francesca Balconi1, Mario Scartozzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31793396     DOI： 10.2217/fon-2019-0624

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

1.  Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients.

Authors:  Stefano Mariani; Marco Puzzoni; Riccardo Giampieri; Pina Ziranu; Valeria Pusceddu; Clelia Donisi; Mara Persano; Giovanna Pinna; Erika Cimbro; Alissa Parrino; Dario Spanu; Andrea Pretta; Eleonora Lai; Nicole Liscia; Alessio Lupi; Enrica Giglio; Grazia Palomba; Milena Casula; Marina Pisano; Giuseppe Palmieri; Mario Scartozzi
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

2.  The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.

Authors:  Nor Isnida Ismail; Iekhsan Othman; Faridah Abas; Nordin H Lajis; Rakesh Naidu
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

Review 3.  Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer.

Authors:  Eleonora Lai; Nicole Liscia; Clelia Donisi; Stefano Mariani; Simona Tolu; Andrea Pretta; Mara Persano; Giovanna Pinna; Francesca Balconi; Annagrazia Pireddu; Valentino Impera; Marco Dubois; Marco Migliari; Dario Spanu; Giorgio Saba; Silvia Camera; Francesca Musio; Pina Ziranu; Marco Puzzoni; Laura Demurtas; Valeria Pusceddu; Manuela Dettori; Elena Massa; Francesco Atzori; Mariele Dessì; Giorgio Astara; Clelia Madeddu; Mario Scartozzi
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

4.  The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Authors:  Pina Ziranu; Eleonora Lai; Marta Schirripa; Marco Puzzoni; Mara Persano; Andrea Pretta; Giada Munari; Nicole Liscia; Valeria Pusceddu; Fotios Loupakis; Laura Demurtas; Michela Libertini; Stefano Mariani; Marco Migliari; Marco Dubois; Riccardo Giampieri; Giovanni Sotgiu; Angelo Paolo Dei Tos; Sara Lonardi; Alberto Zaniboni; Matteo Fassan; Mario Scartozzi
Journal:  Target Oncol       Date:  2021-05-10       Impact factor: 4.493
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.